Literature DB >> 25887388

Update on subclinical Cushing's syndrome.

Lynnette K Nieman1.   

Abstract

PURPOSE OF REVIEW: The present review summarizes recent findings in the diagnosis and treatment of subclinical Cushing's syndrome, a condition of subtle cortisol dysregulation with a spectrum of clinical and biochemical abnormalities. RECENT
FINDINGS: The diagnosis of subclinical Cushing's syndrome is suggested by abnormal suppression to dexamethasone in a patient with an adrenal mass. The natural history of this disorder includes progression in a minority of cases, and increased cardiovascular disease in patients with more severe and progressive disease, much as is found in overt Cushing's syndrome. In patients with an abnormal response to dexamethasone, additional biochemical and metabolic features increase confidence in the ability of adrenalectomy to reverse clinical abnormalities. In addition, bilateral masses and larger masses are more likely to be associated with hypercortisolism.
SUMMARY: We review the recent literature on subclinical cortisol secretion and suggest that additional studies are needed to define optimal diagnostic and therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25887388     DOI: 10.1097/MED.0000000000000159

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  10 in total

1.  Classification and surgical treatment for 180 cases of adrenocortical hyperplastic disease.

Authors:  Yushi Zhang; Hanzhong Li
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  [Clinical analysis of 939 patients with adrenal lesions detected by abdominal computed tomography].

Authors:  Cun-Xia Fan; Jia-Jun Zhang; Ying-Ying Cai; Chun-Yan Wu; Shao-Zhou Zou; Yi-Kai Xu; Yao-Ming Xue; Mei-Ping Guan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-08-20

Review 3.  Approach to the Patient with an Incidental Adrenal Mass.

Authors:  Xin He; Patricia R Peter; Richard J Auchus
Journal:  Med Clin North Am       Date:  2021-09-09       Impact factor: 5.456

Review 4.  [Adrenal incidentaloma : Diagnostic and therapeutic concept from an endocrinological perspective].

Authors:  N Unger
Journal:  Chirurg       Date:  2019-01       Impact factor: 0.955

5.  THE MULTIFARIOUS CUSHING'S - LESSONS FROM A CASE SERIES.

Authors:  I Ilie; V Ciubotaru; A Tulin; D Hortopan; A Caragheorgheopol; M Purice; C Neamtu; V I Elian; A Banica; L Oprea; M Musat
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Apr-Jun       Impact factor: 0.877

Review 6.  The risks of overlooking the diagnosis of secreting pituitary adenomas.

Authors:  Thierry Brue; Frederic Castinetti
Journal:  Orphanet J Rare Dis       Date:  2016-10-06       Impact factor: 4.123

Review 7.  Non-medicalization of medical science: Rationalization for future.

Authors:  Madhukar Mittal; Parth Jethwani; Dukhabandhu Naik; M K Garg
Journal:  World J Methodol       Date:  2022-09-20

8.  Characteristics of Adrenal Incidentalomas in a Large, Prospective Computed Tomography-Based Multicenter Study: The COAR Study in Korea.

Authors:  Seong Hee Ahn; Jae Hyeon Kim; Seung Hee Baek; Hyeonmok Kim; Yoon Young Cho; Sunghwan Suh; Beom Jun Kim; Seongbin Hong; Jung Min Koh; Seung Hun Lee; Kee Ho Song
Journal:  Yonsei Med J       Date:  2018-06       Impact factor: 2.759

Review 9.  Is Follow-up of Adrenal Incidentalomas Always Mandatory?

Authors:  Giuseppe Reimondo; Alessandra Muller; Elisa Ingargiola; Soraya Puglisi; Massimo Terzolo
Journal:  Endocrinol Metab (Seoul)       Date:  2020-03

Review 10.  Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside.

Authors:  Vittoria Favero; Arianna Cremaschi; Chiara Parazzoli; Alberto Falchetti; Agostino Gaudio; Luigi Gennari; Alfredo Scillitani; Fabio Vescini; Valentina Morelli; Carmen Aresta; Iacopo Chiodini
Journal:  Int J Mol Sci       Date:  2022-01-08       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.